Burning Rock Announces an Exclusive in-Licensing of a Risk Stratification Test for Early Stage Lung-Cancer Patients from Oncocyte in China GUANGZHOU, China, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that it entered into an exclusive licensing agreement...

OncoCyte Presents Positive Data from its Liquid Biopsy Breast Cancer Diagnostic Test at the San Antonio Breast Cancer Symposium ALAMEDA, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American:OCX), a developer of novel, non-invasive liquid biopsy tests for the early detection of cancer, today presented...

California Life Sciences Association (CLSA) Adds Leaders from Genentech, Sanford Burnham Prebys Medical Discovery Institute and OncoCyte to Board of Directors SOUTH SAN FRANCISCO and SAN DIEGO, Nov. 23, 2015 (GLOBE NEWSWIRE) -- California Life Sciences Association (CLSA), today announced that its board of directors appointed three new members: William...